Kevin E. Noonan, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP to Speak at The Knowledge Group’s Patent Protection in Life Sciences
The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Kevin E. Noonan, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP will speak at its webcast entitled, “Patent Protection in Life Sciences: Creative Approaches to Safeguard Your Innovations.” This event is scheduled for September 27, 2023, from 12:00 pm to 1:00 pm (ET).
- (1888PressRelease) September 01, 2023 - The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Kevin E. Noonan, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP will speak at its webcast entitled, “Patent Protection in Life Sciences: Creative Approaches to Safeguard Your Innovations.” This event is scheduled for September 27, 2023, from 12:00 pm to 1:00 pm (ET).
For further details, please visit:
https://knowledgewebcasts.com/know-portfolio/patent-protection-in-life-sciences-cle-2023/
About Kevin E. Noonan, Ph.D.
Kevin E. Noonan is co-Chair of MBHB’s Biotechnology and Pharmaceuticals Practice Group. Dr. Noonan is an experienced patent lawyer, molecular biologist and renowned thought leader in biotechnology and pharmaceutical patent law. Over the past 30 years, he has counseled some of the largest biotechnology and pharmaceutical companies in the world on intellectual property issues.
He helps these companies protect their innovations and advance business goals by developing effective patent portfolio strategies. His work includes helping companies develop global patent filing and prosecution strategies, evaluate litigation risks, and manage patent term extensions. Dr. Noonan also has successfully represented clients in numerous interference proceedings. He has filed amicus briefs in landmark cases involving pharmaceutical and biotechnology patent issues to district courts, the Federal Circuit and the U.S. Supreme Court.
Dr. Noonan is the co-founder of and regular contributor to Patent Docs, a website featuring news and commentary on patent law. He is a co-editor and contributing author of the book, “Claim Construction and the Federal Circuit,” and a contributing author of “Antitrust Issues in Intellectual Property Law.” He also regularly speaks about intellectual property issues at events around the world.
Prior to becoming an attorney, Dr. Noonan was a molecular biologist, earning a doctorate from Princeton University, and a National Cancer Institute postdoctoral fellow.
About McDonnell Boehnen Hulbert & Berghoff LLP
McDonnell Boehnen Hulbert & Berghoff LLP (MBHB) provides creative, pragmatic IP business solutions for Fortune 100 companies, midsize companies, startups, and academic institutions. Clients in the U.S. and abroad engage us to secure and enforce their intellectual property rights, from navigating patent office procedures to litigating complex infringement actions. Our attorneys are experienced in the procurement, licensing, enforcement, and defense of patents, trademarks, copyrights, trade secrets, and unfair competition actions in a number of technological disciplines and product categories, including biotechnology and pharmaceuticals, cannabis, chemical, electrical, mechanical and materials, medical device and diagnostics, software and business methods, and telecommunications. Visit mbhb.com for more information on the firm.
Event Summary
Patent litigation remains prolific in the life sciences industry as ensuring protection becomes more challenging and complex due to the involvement of technologies. Some issues plaguing patent owners and intellectual property (IP) lawyers concern the Section 101 jurisprudence related to innovations in the life sciences industry. Moreover, landmark cases like Amgen Inc. v. Sanofi continue to shape the patent landscape, posing profound impacts on invention enablement. These and other developments continue to pose risks that practitioners should be wary of. Canadian jurisprudence deals with similar issues and in some cases, patent practice diverges between the US and Canada.
Listen as experienced patent attorneys Melanie Szweras (Bereskin & Parr LLP) and Kevin E. Noonan, Ph.D. (McDonnell Boehnen Hulbert & Berghoff LLP) provide a comprehensive discussion of the latest trends and challenges in protecting patents in the life science sector. Speakers, among other things, will offer practical tips and strategies for navigating this dynamic regulatory environment.
Key topics include:
• Life Science Patents: Latest Regulatory Developments in the US and Canada
• Current Challenges and Regulatory Issues Faced by Patent Owners and IP Lawyers
• Notable Cases in the US and Canada
• What Lies Ahead
About The Knowledge Group
Founded in November 2006, The Knowledge Group has been at the forefront of providing quality continuing education programs for lawyers, accountants, financial executives, risk and compliance specialists, human resources professionals, technology officers, and business consultants in a wide range of industries.
The Knowledge Group strives to be the best-in-class provider of continuing education by bringing forth relevant content you can’t get anywhere else.
Contact:
Therese Lumbao
Director, Member Services
The Knowledge Group, LLC
info ( @ ) theknowledgegroup dot org
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam